vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and FIRST FINANCIAL CORP (THFF). Click either name above to swap in a different company.
FIRST FINANCIAL CORP is the larger business by last-quarter revenue ($70.5M vs $62.1M, roughly 1.1× Cytek Biosciences, Inc.). FIRST FINANCIAL CORP runs the higher net margin — 30.4% vs -70.9%, a 101.3% gap on every dollar of revenue. On growth, FIRST FINANCIAL CORP posted the faster year-over-year revenue change (14.1% vs 8.1%). FIRST FINANCIAL CORP produced more free cash flow last quarter ($86.4M vs $-1.8M). Over the past eight quarters, FIRST FINANCIAL CORP's revenue compounded faster (20.8% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
First American Financial Corporation is an American financial services company which provides title insurance and settlement services to the real estate and mortgage industries.
CTKB vs THFF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $70.5M |
| Net Profit | $-44.1M | $21.5M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 37.4% |
| Net Margin | -70.9% | 30.4% |
| Revenue YoY | 8.1% | 14.1% |
| Net Profit YoY | -557.1% | 32.1% |
| EPS (diluted) | — | $1.81 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $70.5M | ||
| Q3 25 | $52.3M | $65.8M | ||
| Q2 25 | $45.6M | $63.1M | ||
| Q1 25 | $41.5M | $62.5M | ||
| Q4 24 | $57.5M | $61.8M | ||
| Q3 24 | $51.5M | $58.4M | ||
| Q2 24 | $46.6M | $49.2M | ||
| Q1 24 | $44.9M | $48.4M |
| Q4 25 | $-44.1M | $21.5M | ||
| Q3 25 | $-5.5M | $20.8M | ||
| Q2 25 | $-5.6M | $18.6M | ||
| Q1 25 | $-11.4M | $18.4M | ||
| Q4 24 | $9.6M | $16.2M | ||
| Q3 24 | $941.0K | $8.7M | ||
| Q2 24 | $-10.4M | $11.4M | ||
| Q1 24 | $-6.2M | $10.9M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 37.4% | ||
| Q3 25 | -17.6% | 39.2% | ||
| Q2 25 | -23.3% | 36.2% | ||
| Q1 25 | -36.1% | 38.1% | ||
| Q4 24 | 5.2% | 32.4% | ||
| Q3 24 | -8.2% | 17.9% | ||
| Q2 24 | -18.3% | 27.6% | ||
| Q1 24 | -23.9% | 27.2% |
| Q4 25 | -70.9% | 30.4% | ||
| Q3 25 | -10.5% | 31.6% | ||
| Q2 25 | -12.2% | 29.5% | ||
| Q1 25 | -27.5% | 29.5% | ||
| Q4 24 | 16.8% | 26.3% | ||
| Q3 24 | 1.8% | 15.0% | ||
| Q2 24 | -22.4% | 23.1% | ||
| Q1 24 | -13.8% | 22.6% |
| Q4 25 | — | $1.81 | ||
| Q3 25 | — | $1.75 | ||
| Q2 25 | — | $1.57 | ||
| Q1 25 | — | $1.55 | ||
| Q4 24 | — | $1.37 | ||
| Q3 24 | — | $0.74 | ||
| Q2 24 | — | $0.96 | ||
| Q1 24 | — | $0.93 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | — |
| Total DebtLower is stronger | — | $188.2M |
| Stockholders' EquityBook value | $341.7M | $650.9M |
| Total Assets | $461.5M | $5.8B |
| Debt / EquityLower = less leverage | — | 0.29× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — | ||
| Q1 24 | $168.8M | — |
| Q4 25 | — | $188.2M | ||
| Q3 25 | — | $170.5M | ||
| Q2 25 | — | $122.7M | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $28.1M | ||
| Q3 24 | — | $30.5M | ||
| Q2 24 | — | $108.6M | ||
| Q1 24 | — | $58.6M |
| Q4 25 | $341.7M | $650.9M | ||
| Q3 25 | $378.6M | $622.2M | ||
| Q2 25 | $377.6M | $587.7M | ||
| Q1 25 | $379.6M | $571.9M | ||
| Q4 24 | $395.7M | $549.0M | ||
| Q3 24 | $385.5M | $566.0M | ||
| Q2 24 | $389.1M | $530.7M | ||
| Q1 24 | $392.6M | $520.8M |
| Q4 25 | $461.5M | $5.8B | ||
| Q3 25 | $494.9M | $5.7B | ||
| Q2 25 | $493.3M | $5.6B | ||
| Q1 25 | $482.6M | $5.5B | ||
| Q4 24 | $499.5M | $5.6B | ||
| Q3 24 | $491.2M | $5.5B | ||
| Q2 24 | $483.7M | $4.9B | ||
| Q1 24 | $492.1M | $4.9B |
| Q4 25 | — | 0.29× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.21× | ||
| Q1 25 | — | 0.22× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | — | 0.05× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | — | 0.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $90.4M |
| Free Cash FlowOCF − Capex | $-1.8M | $86.4M |
| FCF MarginFCF / Revenue | -2.9% | 122.5% |
| Capex IntensityCapex / Revenue | 1.6% | 5.6% |
| Cash ConversionOCF / Net Profit | — | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $144.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $90.4M | ||
| Q3 25 | $-3.9M | $26.9M | ||
| Q2 25 | $108.0K | $12.7M | ||
| Q1 25 | $-125.0K | $21.1M | ||
| Q4 24 | $2.0M | $60.4M | ||
| Q3 24 | $13.2M | $23.3M | ||
| Q2 24 | $6.2M | $8.8M | ||
| Q1 24 | $4.0M | $12.4M |
| Q4 25 | $-1.8M | $86.4M | ||
| Q3 25 | $-4.6M | $25.8M | ||
| Q2 25 | $-1.5M | $11.6M | ||
| Q1 25 | $-974.0K | $20.5M | ||
| Q4 24 | $1.1M | $54.3M | ||
| Q3 24 | $12.2M | $19.5M | ||
| Q2 24 | $5.2M | $8.4M | ||
| Q1 24 | $3.4M | $11.5M |
| Q4 25 | -2.9% | 122.5% | ||
| Q3 25 | -8.7% | 39.2% | ||
| Q2 25 | -3.2% | 18.4% | ||
| Q1 25 | -2.3% | 32.8% | ||
| Q4 24 | 1.9% | 87.8% | ||
| Q3 24 | 23.7% | 33.5% | ||
| Q2 24 | 11.0% | 17.2% | ||
| Q1 24 | 7.6% | 23.7% |
| Q4 25 | 1.6% | 5.6% | ||
| Q3 25 | 1.3% | 1.7% | ||
| Q2 25 | 3.5% | 1.8% | ||
| Q1 25 | 2.0% | 0.9% | ||
| Q4 24 | 1.6% | 9.9% | ||
| Q3 24 | 2.0% | 6.5% | ||
| Q2 24 | 2.3% | 0.7% | ||
| Q1 24 | 1.3% | 2.0% |
| Q4 25 | — | 4.21× | ||
| Q3 25 | — | 1.29× | ||
| Q2 25 | — | 0.68× | ||
| Q1 25 | — | 1.14× | ||
| Q4 24 | 0.21× | 3.72× | ||
| Q3 24 | 14.05× | 2.67× | ||
| Q2 24 | — | 0.77× | ||
| Q1 24 | — | 1.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
THFF
Segment breakdown not available.
